Nucleic acid sequence amplification method, composition and kit

• US 5,554,516 A
• Filed: 12/02/1993
• Issued: 09/10/1996
• Est. Priority Date: 05/06/1992
• Status: Expired due to Term

• Current Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Original Assignee: Gen-Probe Incorporated (Hologic Incorporated)
• Inventors: Kacian, Daniel L., Dattagupta, Nanibhushan, McDonough, Sherrol H., McAllister, Diane L.
• Primary Examiner(s): Jones, W. Gary
• Assistant Examiner(s): MYERS, CARLA J
• Application Number:
  US08/162,836
• Time in Patent Office: 1,013 Days
• Field of Search: 435/91.2, 435/6, 435/91.21, 435/91.5, 435/91.51, 435/91.53, 536/24.32, 536/24.33, 514/44, 935/17, 935/18, 935/8, 935/77, 935/78
• US Class Current: 435/91.21
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
• CPC Class Codes: C12Q 1/6848 characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
• CPC Class Codes: C12Q 1/686 Polymerase chain reaction [PCR]
• CPC Class Codes: C12Q 1/6865 Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]
• CPC Class Codes: C12Q 1/689 for bacteria

Abstract

A method, composition and kit for amplifying a target nucleic acid sequence under conditions of substantially constant temperature, ionic strength, and pH and using only a single promoter-primer. To effect the amplification, a supply of a single promoter-primer having a promoter and a primer complementary to the 3'"'"'-end of the target sequence, and a reverse transcriptase and an RNA polymerase are provided to a mixture including the target sequence; the amplification proceeds accordingly. The invention is useful for generating copies of a nucleic acid target sequence for purposes that include assays to quantitate specific nucleic acid sequences in clinical, environmental, forensic and similar samples, cloning and generating probes.

Claims

1. A method of amplifying a target ribonucleic acid sequence comprising the following steps:

a) incubating a mixture comprising;

a target nucleic acid comprising said target ribonucleic acid sequence,

one or more promoter-primers comprising a single nucleic acid sequence comprising a promoter recognizable by an RNA polymerase and a primer located 3'"'"' relative to said promoter, said primer being sufficiently complementary to said target nucleic acid to form a promoter-primer;

target nucleic acid complex at or near the 3'"'"'-end of said target ribonucleic acid sequence, and able to be extended to form a complement of said target ribonucleic acid sequence by a DNA polymerase,

said DNA polymerase, and said RNA polymerase,

at a temperature and in a solution effective to allow amplification of said target ribonucleic acid sequence, said mixture lacking a primer which forms a hybrid with said complement of said target ribonucleic acid sequence; and

b) producing multiple copies of an RNA sequence complementary to said target ribonucleic acid sequence using said target ribonucleic acid sequence as a template.

2. The method of claim 1 wherein said DNA polymerase is a reverse transcriptase.

3. The method of claim 1 or 2 wherein said incubation is at essentially constant temperature.

4. The method of claim 1 or 2 wherein said target ribonucleic acid sequence and said one or more promoter-primers are incubated together prior to addition of said DNA polymerase and said RNA polymerase.

5. The method of claim 1 or 2 wherein said solution further comprises RNAse H activity.

6. The method of claim 1 or 2, wherein said solution further comprises an agent to create a definition at a 5'"'"'-end of said target ribonucleic acid sequence such that an extension reaction involving said target ribonucleic acid sequence will stop at said definition.

7. The method of claim 6, wherein said agent comprises a defining nucleic acid sequence sufficiently complementary to said 5'"'"'-end of said target ribonucleic acid sequence to be able to complex with said 5'"'"'-end of said target ribonucleic acid at said temperature and in said solution.

8. The method of claim 1 or 2, wherein said target nucleic acid comprises nucleotides at its 3'"'"'-end that are not within said promoter-primer:

target nucleic acid complex.

9. The method of claim 1 or 2, wherein said 3'"'"'-end of said target nucleic acid is generated by chemical or enzymatic degradation or processing.

10. The method of claim 9 wherein said chemical or enzymatic degradation or processing comprises treatment with an exonuclease.

11. The method of claim 1 or 2, wherein said mixture further comprises one or more helper oligonucleotides.

12. The method of claim 1 or 2 wherein said RNA polymerase is a DNA-dependent RNA polymerase.

13. The method of claim 12 wherein said DNA-dependent RNA polymerase is selected from the group consisting of T7 RNA polymerase, T3 RNA polymerase and SP6 RNA polymerase.

14. The method of claim 1 or 2, wherein said mixture is screened by hybridization with a probe after said incubation.

29. The method of claim 2 wherein said incubating is performed in the presence of one or more of DMSO and glycerol.

30. The method of claim 5, wherein said target nucleic acid comprises nucleotides located 3'"'"' of said promoter-primer:

target nucleic acid complex.

15. A method of amplifying a target ribonucleic acid sequence comprising the steps of:

a) incubating a mixture consisting essentially of;

a target nucleic acid comprising said target ribonucleic acid sequence,

a supply of promoter-primers comprising a single nucleic acid sequence comprising a promoter recognizable by an RNA polymerase and a primer located 3'"'"' relative to said promoter, said primer being sufficiently complementary to said target ribonucleic acid to form a promoter-primer;

target nucleic acid complex at or near the 3'"'"'-end of said target ribonucleic acid sequence, said supply comprising one or more modified promoter-primers and one or more unmodified promoter-primers, wherein the ratio of said one or more modified promoter-primers to said one or more unmodified promoter-primers is effective to produce greater amplification compared to said one or more modified promoter-primers or said one or more unmodified promoter primers alone,

a reverse transcriptase, and said RNA polymerase,

at a temperature and in a solution effective to allow amplification of said target ribonucleic acid sequence, said incubating comprising essentially constant temperature during said amplification; and

b) producing multiple copies of an RNA sequence complementary to said target ribonucleic sequence using said target ribonucleic acid sequence as a template.

16. The method of claim 15, wherein said solution further comprises an agent which defines a 5'"'"'-end of said target ribonucleic acid sequence such that any extension reaction involving said target ribonucleic acid sequence will stop at said definition.

17. The method of claim 15 wherein said target nucleic acid comprises nucleotides located 3'"'"' of said promoter-primer:

target nucleic acid complex.

18. The method of claim 15 wherein said reverse transcriptase is AMV or MMLV reverse transcriptase.

19. The method of claim 15 or 18, wherein each of said one or more modified promoter-primers independently have a modification selected from the group consisting of, 3'"'"' terminal phosphorothioate deoxyribonucleotide, non-nucleotide linkage, 3'"'"'-alkane-diol residue, and 3'"'"'-cordycepin.

20. The method of claim 15, wherein said mixture further comprises one or more helper oligonucleotides.

21. A method for amplifying a target ribonucleic acid sequence, comprising the steps of:

a) contacting said target ribonucleic acid sequence with a plurality of promoter-primers comprising a single nucleic acid sequence comprising a promoter recognizable by an RNA polymerase and a primer located 3'"'"' relative to said promoter, said primer being able to complex at or near a 3'"'"'-end of said target ribonucleic acid sequence, and wherein one or more of said plurality of promoter-primers is an unmodified promoter-primer and one or more of said plurality of promoter-primers is a modified promoter-primer comprising a modified nucleotide at its 3'"'"'-end to prevent or decrease a nucleic acid extension reaction from proceeding therefrom, under conditions effective to allow said amplifying; and

b) producing multiple copies of an RNA sequence complementary to said target ribonucleic acid sequence.

22. A composition for amplifying a target ribonucleic acid sequence using said target ribonucleic acid sequence as a template comprising:

said target ribonucleic acid sequence,

one or more promoter-primers comprising a single nucleic acid sequence comprising a promoter recognizable by an RNA polymerase and a primer located 3'"'"' relative to said promoter, said primer being sufficiently complementary to said target ribonucleic acid sequence to form a complex at or near the 3'"'"'-end of said target ribonucleic acid sequence,

a reverse transcriptase,

said RNA polymerase, and

a solution of reagents able to allow amplification of said target ribonucleic acid sequence at essentially constant temperature;

wherein a primer able to hybridize to a nucleic acid sequence complementary to said target sequence is not present.

23. The composition of claim 22 further comprising a defining oligonucleotide sufficiently complementary to a 5'"'"'-end of said target nucleic acid sequence to form a complex with said 5'"'"'-end of said target nucleic acid sequence at said temperature and in said solution.

25. The composition of claim 22 wherein said reverse transcriptase is AMV or MMLV reverse transcriptase.

26. The composition of claim 22 further comprising one or more helper oligonucleotides.

27. The composition of claim 22 wherein said RNA polymerase is selected from the group consisting of T7 RNA polymerase, T3 RNA polymerase and SP6 RNA polymerase.

24. The composition of 22 wherein said target ribonucleic acid sequence is present on RNA which comprises nucleotides located 3'"'"' of said complex.

28. Nucleic acid consisting of a sequence chosen from the group consisting of:

SEQ ID No 6, SEQ ID No 8, and SEQ ID No 9.

31. A method of amplifying a target ribonucleic acid sequence comprising the following steps:

a) incubating a mixture comprising;

a target nucleic acid comprising said target ribonucleic acid sequence,

one or more promoter-primers comprising a single nucleic acid sequence comprising a promoter recognizable by an RNA polymerase and a primer located 3'"'"' relative to said promoter, said primer being sufficiently complementary to said target nucleic acid to form a promoter-primer;

target nucleic acid complex at or near the 3'"'"'-end of said target ribonucleic acid sequence,

a DNA polymerase, and

said RNA polymerase,

at a temperature and in a solution effective to allow amplification of said target ribonucleic acid sequence, wherein said mixture lacks a primer which forms a hybrid with said complement of said target ribonucleic acid sequence; and

b) producing multiple copies of an RNA sequence complementary to said target ribonucleic acid sequence using said target ribonucleic acid sequence as a template;

wherein at least one of said one or more promoter-primers is a modified promoter-primer comprising a modification at its 3'"'"'-end to prevent or decrease a nucleic acid extension reaction from proceeding therefrom.

32. The method of claim 31, wherein said DNA polymerase is a reverse transcriptase.

33. The method of claim 32, wherein said one or more promoter-primers comprise one or more unmodified promoter-primers.

34. The method of claim 32, wherein said one or more promoter-primers comprises one or more modified promoter-primers and one or more unmodified promoter-primers, wherein said one or more modified promoter-primers and said one or more unmodified promoter-primers are present in a ratio of between about 150:

1 and about 1;

1, respectively.

35. The method of any of claims 31-34, wherein said modification is selected from the group consisting of, one or more ribonucleotide, 3'"'"' terminal phosphorothioate deoxyribonucleotide, nonnucleotide linkage, 3'"'"'-alkane-diol residue, and 3'"'"'-cordycepin.

36. The method of claim 32 or 33, wherein said reverse transcriptase is either AMY or MMLV reverse transcriptase.

37. The method claim 36, wherein said modification is selected from the group consisting of, one or more ribonucleotide, 3'"'"' terminal phosphorothioate deoxyribonucleotide, nonnucleotide linkage, 3'"'"'-alkane-diol residue, and 3'"'"'-cordycepin.

38. A composition for amplifying a target ribonucleic acid sequence using said target ribonucleic acid sequence as a template comprising:

said target ribonucleic acid sequence, and

one or more promoter-primers comprising a single nucleic acid sequence comprising a promoter recognizable by an RNA polymerase and a primer located 3'"'"' relative to said promoter, said primer being sufficiently complementary to said target ribonucleic acid sequence to form a complex at or near the 3'"'"'-end of said target ribonucleic acid sequence,

a reverse transcriptase,

said RNA, and

a solution of reagents able to allow amplification of said target ribonucleic acid sequence at essentially constant temperature;

wherein a primer able to hybridize to a nucleic acid sequence complementary to said target ribonucleic acid sequence is not present;

wherein said one or more promoter-primers comprises one or more modified promoter-primers and one or more unmodified promoter-primers, said one or more modified promoter-primers and said one or more unmodified promoter primers being present in a ratio effective to produce amplification.

39. The composition of claim 38, wherein said ratio of one more modified promoter-primers to one or more unmodified promoter-primers is between about 150:

1 and about 1;

1, respectively.

40. The composition of claim 38 or 39, wherein each of said one or more modified promoter-primers have a modification selected from the group consisting of, one or more ribonucleotide, 3'"'"' terminal phosphorothioate deoxyribonucleotide, non-nucleotide linkage, 3'"'"'-alkane-diol residue, and 3'"'"'-cordycepin.

41. The composition of claim 40, wherein said modification is said 3'"'"'-alkane-diol residue.